The United Kingdom’s stock market has been under pressure recently, with the FTSE 100 index experiencing declines due to weak trade data from China and falling commodity prices. As global economic uncertainties weigh on investor sentiment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
Name
Current Price
Fair Value (Est)
Discount (Est)
Tristel (AIM:TSTL)
£4.075
£7.59
46.3%
Playtech (LSE:PTEC)
£3.384
£6.60
48.7%
Oxford Biomedica (LSE:OXB)
£6.35
£12.25
48.2%
Mitie Group (LSE:MTO)
£1.70
£3.38
49.7%
James Fisher and Sons (LSE:FSJ)
£5.02
£9.97
49.6%
Fevertree Drinks (AIM:FEVR)
£7.80
£14.92
47.7%
Entain (LSE:ENT)
£5.266
£10.04
47.6%
Convatec Group (LSE:CTEC)
£2.054
£4.07
49.5%
B90 Holdings (AIM:B90)
£0.023
£0.045
49.1%
Advanced Medical Solutions Group (AIM:AMS)
£2.49
£4.87
48.8%
Let’s explore several standout options from the results in the screener.
Overview: CAB Payments Holdings Limited offers business-to-business cross-border payments and foreign exchange services across multiple regions including the Americas, the UK, Europe, Africa, the Middle East, and Asia with a market capitalization of £203.09 million.
Operations: The company’s revenue is primarily derived from its business-to-business cross-border payments and foreign exchange services, amounting to £86.08 million.
Estimated Discount To Fair Value: 30.1%
CAB Payments Holdings appears undervalued, trading at £0.8 against a future cash flow value of £1.14, representing a discount of over 20%. The company’s earnings and revenue are projected to grow significantly faster than the UK market, with expected annual profit growth of 24.8% and revenue growth of 16%. Recent M&A interest from StoneX Group highlighted CAB’s perceived undervaluation, though the acquisition offer was ultimately rejected for not aligning with its future prospects.
LSE:CABP Discounted Cash Flow as at May 2026
Overview: CVS Group plc operates veterinary services, an online pharmacy, and retail businesses in the United Kingdom and Australia, with a market cap of £800.49 million.
Operations: The company generates revenue from its segments, including £632.70 million from Veterinary Practices, £33 million from Laboratories, and £47.90 million from its Online Retail Business.
Story continues
